Previous 10 | Next 10 |
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Guardant Health’s management is scheduled to present on Monday, January 10 at 12:00 p.m. ...
Intercontinental Exchange will add 138 securities to the ICE Biotechnology index and delete 26 as part of the annual reconstitution, effective prior to market open on December 20. Notable additions: Aurinia Pharmaceuticals (NASDAQ:AUPH), Anavex Life Sciences (NASDAQ:AVXL), Sesen Bio...
Topline Data Release from ECLIPSE Planned for Mid-2022 Subject to Positive Study Outcome, Data Will Support a Premarket Approval (PMA) Submission to the U.S. FDA in 2022 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has rea...
Halvorsen's 13F portfolio value increased from $32.98B to $36.04B this quarter. The number of positions increased from 88 to 96. Viking Global added McDonald’s and increased General Electric, Humana, Brookfield Asset Management, and Parker Hannifin while dropping Aon plc during...
Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms. Biotech stocks are having a difficult year, in spite of many of those trading at dirt-cheap valuations that don't even reflect the cash they have in-hand. It's very l...
GuardantINFORM ™ platform offers real-world evidence to identify unmet need for patients with advanced breast cancer sGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present new data demonstrating the benefits of u...
Corporate insiders rang the bell on the market almost three weeks ago with elevated levels of insider selling. A third insider of a trillion-dollar market cap company joined the selling spree last week with Microsoft CEO Satya Nadella selling almost exactly half of his shares over. ...
Goldman Sachs identifies changes in popularity for stocks among hedge funds for indications of potential outperformance and underperformance. "During the last 19 years, stocks with the largest increase in the number of hedge fund investors ('Rising Stars') have typically gone on to outperform...
Guardant Health (GH +12.8%) co-CEO, AmirAli Talasaz bought 104,500 shares, bringing total share count to ~1.85M. Co-CEO, Helmy Eltoukhy bought 104,500 shares, bringing total share count to ~1.96M. News from last month, 'Guardant Health rebounds after deciding against buying NeoGenomics' For...
The study, published in Nature Medicine , demonstrates that the Guardant360 ® test helps identify patients who may benefit from treatment and can identify alterations that predict resistance Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology co...
News, Short Squeeze, Breakout and More Instantly...
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance requirements for Medicare coverage Blood test offers easy, convenient and pleasant screening option with potential for improving colorectal cancer screening rates ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...